biotechnology - International Biopharmaceutical Industry

news

A promising cancer drug leads Regeneron to reconsider its aversion to M&A

Dive Brief: Regeneron has agreed to purchase a young biotechnology company for access to a drug that the buyer believes will be a valuable component in cancer-figh...

25 April 2022 news biotechnology | cancer

Continue Reading →

news

Regeneron, in search of an eye gene therapy, turns to a young biotech

Dive Brief: Through a deal announced Wednesday, a German-based biotechnology company has agreed to help Regeneron develop a gene therapy for an inherited retinal d...

11 April 2022 news biotechnology | eye

Continue Reading →

news

CHARNWOOD MOLECULAR UNVEILS CUTTING EDGE LABORATORIES

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has officially opened its new facilitie...

8 April 2022 news biotechnology | Charnwood

Continue Reading →

news

Yumanity cutting 60% of employees as it mulls possible sale

Dive Brief: On the heels of a recent setback, Yumanity Therapeutics, a biotechnology company focused on neuroscience, plans to eliminate about 60% of its workforce...

18 February 2022 news biotechnology | costs

Continue Reading →

news

Editas’ executive shake up continues

Dive Brief: Editas Medicine, a biotechnology company focused on CRISPR gene editing, has fired its chief medical officer, adding to a series of executive-level cha...

10 February 2022 news biotechnology | company

Continue Reading →